4 Results for "

Ralaniten

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Ralaniten" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-150102
CAS No.: 2139288-26-7
Purity:  99.86%
Target:  

Androgen Receptor

Research Areas:  

Cancer

EPI-7170, a ralaniten analogue, is a potent androgen receptor N-terminal structural domain antagonist that blocks the transcriptional activity of full-length AR (FL-AR) and AR splice variants (AR-Vs). EPI-7170 has antitumor effects against enzalutamide resistant castration-resistant prostate cancer (CRPC) .
loading...
    loading...
Cat. No.: HY-109070
CAS No.: 1203490-23-6
Purity:  99.78%
Synonyms: EPI-002
Target:  

Androgen Receptor

Research Areas:  

Cancer

Ralaniten (EPI-002) is a potent and orally active antagonist of the androgen receptor-N-terminal domain (AR-NTD). Ralaniten inhibits AR transcriptional activity, with IC50 of 7.4 μM. Ralaniten can be used for the research of castration-resistant prostate cancer (CRPC) .
loading...
    loading...
Cat. No.: HY-123875A
CAS No.: 1637573-04-6
Purity:  98.79%
Synonyms: EPI-506
Target:  

Androgen Receptor

Research Areas:  

Cancer

Ralaniten triacetate (EPI-506), the pro-agent of Ralaniten, is a first-in-class, orally active androgen receptor (AR) N-terminal domain (NTD) inhibitor. Ralaniten triacetate shows activity against both full length and resistance-related AR species, including AR-v7 .
loading...
    loading...
Cat. No.: HY-109070R
CAS No.: 1203490-23-6
Synonyms: EPI-002 (Standard)
Research Areas:  

Cancer

Ralaniten (Standard) is the analytical standard of Ralaniten (HY-109070). This product is intended for research and analytical applications. Ralaniten (EPI-002) is a potent and orally active antagonist of the androgen receptor-N-terminal domain (AR-NTD). Ralaniten inhibits AR transcriptional activity, with IC50 of 7.4 μM. Ralaniten can be used for the research of castration-resistant prostate cancer (CRPC) .
loading...
    loading...